Winbp 20 Tablet contains Olmesartan Medoxomil 20 mg, an angiotensin II receptor blocker (ARB) used primarily for the management of hypertension. Olmesartan Medoxomil works by selectively inhibiting the binding of angiotensin II to the AT1 receptor found in various tissues, including vascular smooth muscle and the adrenal gland, thereby preventing vasoconstriction and aldosterone secretion. This leads to vasodilation, reduced peripheral resistance, and ultimately a decrease in blood pressure. Winbp 20 is indicated for the treatment of high blood pressure in adults, helping to reduce the risk of cardiovascular events such as stroke and myocardial infarction associated with hypertension. The medication is generally well tolerated, with common adverse effects including dizziness, headache, and fatigue. It is contraindicated in patients with hypersensitivity to Olmesartan or any component of the formulation, and caution is advised in patients with renal impairment or volume depletion. Regular monitoring of blood pressure, renal function, and electrolytes is recommended during therapy. Winbp 20 should be used under medical supervision, adhering to prescribed dosages to achieve optimal blood pressure control and minimize potential side effects.